Selank
Tuftsin analog heptapeptide
An anxiolytic peptide studied for stress response without the sedation or dependence profile of benzodiazepines.
How it works
Modulates GABA-A receptor expression and enkephalin degradation while raising BDNF, producing anxiolysis through a different route than direct GABA agonism.
What research has shown
Clinical work in generalized anxiety reports symptom reduction comparable to medazepam in Russian trials, with fewer sedative effects.
Reported ranges in the literature
Low end
250 mcg daily intranasal
Optimal
300 to 900 mcg daily
High end
1.5 mg daily in reported protocols
Frequency reported in the literature: Daily in 10 to 14 day courses
Protocol duration and pairing
Typical study duration
10 to 30 day courses.
Research use only
All content on this page is general reference information for laboratory research contexts. It is not medical advice, is not intended to direct human use, and does not replace guidance from a licensed healthcare professional. Not for human consumption. Must be 18+.